[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
[ Thu, Feb 24th 2022 ]: WOPRAI
Michael King Maintained (AGIO) at Strong Buy with Decreased Target to $96 on, Feb 24th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Michael King of HC Wainwright & Co., Maintained "Agios Pharmaceuticals, Inc." (AGIO) at Strong Buy with Decreased Target from $98 to $96 on, Feb 24th, 2022.
Michael has made no other calls on AGIO in the last 4 months.
There are 3 other peers that have a rating on AGIO. Out of the 3 peers that are also analyzing AGIO, 1 agrees with Michael's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Andrew Berens of "SVB Leerink" Maintained at Hold with Decreased Target to $30 on, Tuesday, February 22nd, 2022
These are the ratings of the 2 analyists that currently disagree with Michael
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $44 on, Wednesday, February 16th, 2022
- Greg Harrison of "B of A Securities" Initiated at Strong Buy and Held Target at $54 on, Friday, December 3rd, 2021